Analystreport

SpringWorks Therapeutics (NASDAQ: SWTX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $33.00 price target on the stock.

SpringWorks Therapeutics, Inc. - common stock  (SWTX) 
Last springworks therapeutics, inc. - common stock earnings: 3/12 04:30 pm Check Earnings Report